Search by Drug Name or NDC

    NDC 43386-0711-03 Quinapril HCL and Hydrochlorothiazide 12.5; 20 mg/1; mg/1 Details

    Quinapril HCL and Hydrochlorothiazide 12.5; 20 mg/1; mg/1

    Quinapril HCL and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals,Inc.. The primary component is HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE.

    Product Information

    NDC 43386-0711
    Product ID 43386-711_1f5e9cdc-ae57-4198-bb48-bd31efe86921
    Associated GPIs 36991802650330
    GCN Sequence Number 024002
    GCN Sequence Number Description quinapril/hydrochlorothiazide TABLET 20-12.5 MG ORAL
    HIC3 A4J
    HIC3 Description ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC
    GCN 54161
    HICL Sequence Number 007826
    HICL Sequence Number Description QUINAPRIL HCL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Quinapril HCL and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Quinapril HCL and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 20
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
    Labeler Name Lupin Pharmaceuticals,Inc.
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076374
    Listing Certified Through 2024-12-31

    Package

    NDC 43386-0711-03 (43386071103)

    NDC Package Code 43386-711-03
    Billing NDC 43386071103
    Package 30 TABLET in 1 BOTTLE (43386-711-03)
    Marketing Start Date 2012-06-18
    NDC Exclude Flag N
    Pricing Information N/A